|
| 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxamide, 2-(1H-imidazol-1-yl)-N-[trans-4-(2-methoxyethoxy)cyclohexyl]- Basic information |
| 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxamide, 2-(1H-imidazol-1-yl)-N-[trans-4-(2-methoxyethoxy)cyclohexyl]- Chemical Properties |
density | 1.43±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 250 mg/mL (650.31 mM; Need ultrasonic) | pka | 11.41±0.40(Predicted) |
| 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxamide, 2-(1H-imidazol-1-yl)-N-[trans-4-(2-methoxyethoxy)cyclohexyl]- Usage And Synthesis |
Biological Activity | RBN013209 is a potent CD38 inhibitor and is useful in the treatment of cancer. | References | [1]. Laurie B. Schenkel, et al. Heterobicyclic amides as inhibitors of cd38. WO2021021986 A1. |
| 5H-Pyrrolo[3,2-d]pyrimidine-4-carboxamide, 2-(1H-imidazol-1-yl)-N-[trans-4-(2-methoxyethoxy)cyclohexyl]- Preparation Products And Raw materials |
|